DUBLIN--(BUSINESS WIRE)--Sep 10, 2018--The “In Vitro Fertilization (IVF) Market by Cycle Type and End User - Global Opportunity Analysis and Industry Forecast, 2014 - 2022” report has been added to ResearchAndMarkets.com’s offering.
The world IVF market accounted for $9,015 million in 2015 and is projected to garner revenues worth $17,714 million by 2022, registering a CAGR of 10.2% over the forecast period.
The growth of the market is attributed to the reduced conceiving rates, delayed pregnancy, changing lifestyle conditions and fertility disorders are the major factors that drive the market growth. Other factors such as favourable reimbursement scenario and delayed parenthood opted by couples due to professional and financial constraints will also help in the growth of the market.
On the other hand, barriers such as ethical concerns in particular countries with respect to IVF, high cost of the IVF procedures followed by low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.
Rising initiatives towards commercialization of cost-efficient treatments and emerging medical tourism, mainly in developing nations would offer lucrative growth opportunities for IVF service providers in future. Further, the growing clinical research initiatives for the development of novel IVF technologies would provide a platform for growth of the global IVF market.
The world IVF market is segmented on the basis of cycle type, end users and geography.
Based on cycle types, the market is segmented into fresh cycle (non-donor), thawed IVF cycle (non-donor) and donor egg IVF cycles. Fresh cycle (non-donor) is both the highest revenue generating segment as well as the highest growing segment as it is the most commonly adopted method in a IVF process due to high success rate.
Companies ProfiledClinique De La Muette DRK Kliniken Berlin Heidelberg University Hospital Hopital Des Metallurgistes, Hopital Cochin Klinikum Stuttgart University Medical Center Freiburg
For more information about this report visit https://www.researchandmarkets.com/research/lgtnw4/global_invitro?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180910005415/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Women’s Health
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL BABY/MATERNITY CONSUMER
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/10/2018 06:35 AM/DISC: 09/10/2018 06:35 AM